Shares of Transcat, Inc. (NASDAQ:TRNS) have been given an average broker rating score of 1.50 (Buy) from the two analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company.
Analysts have set a twelve-month consensus price target of $20.00 for the company and are expecting that the company will post $0.18 earnings per share for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 60 out of 265 based on the ratings given to its competitors.
A number of research firms recently issued reports on TRNS. Zacks Investment Research raised shares of Transcat from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a report on Saturday, February 3rd. Singular Research raised their price objective on shares of Transcat from $15.30 to $20.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Finally, Roth Capital began coverage on shares of Transcat in a report on Friday. They issued a “buy” rating and a $20.00 price objective on the stock.
In related news, Director John T. Smith sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $15.70, for a total value of $31,400.00. Following the transaction, the director now owns 33,100 shares of the company’s stock, valued at $519,670. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 8.80% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TRNS. Northern Trust Corp raised its stake in Transcat by 9.5% during the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock worth $220,000 after acquiring an additional 1,570 shares during the period. Wedge Capital Management L L P NC bought a new stake in Transcat during the 4th quarter worth approximately $378,000. QCI Asset Management Inc. NY raised its stake in Transcat by 31.1% during the 3rd quarter. QCI Asset Management Inc. NY now owns 32,234 shares of the scientific and technical instruments company’s stock worth $437,000 after acquiring an additional 7,647 shares during the period. Quantum Capital Management bought a new stake in Transcat during the 3rd quarter worth approximately $696,000. Finally, Vanguard Group Inc. raised its stake in Transcat by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock worth $1,623,000 after acquiring an additional 4,450 shares during the period. Institutional investors own 56.53% of the company’s stock.
Transcat (TRNS) opened at $15.65 on Thursday. The company has a quick ratio of 1.53, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock has a market cap of $111.94, a P/E ratio of 24.45, a P/E/G ratio of 2.96 and a beta of 0.40. Transcat has a 1-year low of $11.02 and a 1-year high of $16.49.
Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.09. The company had revenue of $40.48 million for the quarter. Transcat had a net margin of 3.24% and a return on equity of 10.03%. analysts expect that Transcat will post 0.66 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://ledgergazette.com/2018/02/11/zacks-analysts-set-20-00-price-target-for-transcat-inc-trns.html.
Transcat Company Profile
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.